These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 17618619)
21. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. Biezonski DK; Meyer JS J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520 [TBL] [Abstract][Full Text] [Related]
22. The effect of psychostimulants on [3H]dopamine uptake and release in rat brain synaptic vesicles. Schwartz K; Weizman A; Rehavi M J Neural Transm (Vienna); 2006 Sep; 113(9):1347-52. PubMed ID: 16362637 [TBL] [Abstract][Full Text] [Related]
26. Cocaine, but not amphetamine, short term treatment elevates the density of rat brain vesicular monoamine transporter 2. Schwartz K; Nachman R; Yossifoff M; Sapir R; Weizman A; Rehavi M J Neural Transm (Vienna); 2007; 114(4):427-30. PubMed ID: 16897597 [TBL] [Abstract][Full Text] [Related]
27. Effects of amphetamine, methylphenidate, atomoxetine, and morphine in rats responding under an adjusting stop signal reaction time task. Maguire DR; France CP Psychopharmacology (Berl); 2019 Jun; 236(6):1959-1972. PubMed ID: 30798404 [TBL] [Abstract][Full Text] [Related]
28. Similar effects of amphetamine and methylphenidate on the performance of complex operant tasks in rats. Mayorga AJ; Popke EJ; Fogle CM; Paule MG Behav Brain Res; 2000 Apr; 109(1):59-68. PubMed ID: 10699658 [TBL] [Abstract][Full Text] [Related]
29. Chronic methylphenidate treatment during adolescence has long-term effects on monoaminergic function. Di Miceli M; Omoloye A; Gronier B J Psychopharmacol; 2019 Jan; 33(1):109-121. PubMed ID: 30334678 [TBL] [Abstract][Full Text] [Related]
30. Stereotyped behavior: effects of d-amphetamine and methylphenidate in the young rat. Roffman JL; Raskin LA Pharmacol Biochem Behav; 1997 Dec; 58(4):1095-102. PubMed ID: 9408219 [TBL] [Abstract][Full Text] [Related]
31. Role of Organic Cation Transporter 3 and Plasma Membrane Monoamine Transporter in the Rewarding Properties and Locomotor Sensitizing Effects of Amphetamine in Male andFemale Mice. Clauss NJ; Koek W; Daws LC Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948221 [TBL] [Abstract][Full Text] [Related]
35. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Lin JS; Hou Y; Jouvet M Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14128-33. PubMed ID: 8943072 [TBL] [Abstract][Full Text] [Related]
36. Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: an in-vitro study in human neuronal and immune cells. Schmidt AJ; Krieg JC; Clement HW; Gebhardt S; Schulz E; Heiser P J Psychopharmacol; 2010 Dec; 24(12):1829-33. PubMed ID: 19605603 [TBL] [Abstract][Full Text] [Related]
38. Abuse liability assessment in preclinical drug development: predictivity of a translational approach for abuse liability testing using methylphenidate in four standardized preclinical study models. Teuns GB; Geys HM; Geuens SM; Stinissen P; Meert TF J Pharmacol Toxicol Methods; 2014; 70(3):295-309. PubMed ID: 24632211 [TBL] [Abstract][Full Text] [Related]
39. Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge. Devilbiss DM; Berridge CW J Pharmacol Exp Ther; 2006 Dec; 319(3):1327-35. PubMed ID: 16980569 [TBL] [Abstract][Full Text] [Related]
40. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. Easton N; Steward C; Marshall F; Fone K; Marsden C Neuropharmacology; 2007 Feb; 52(2):405-14. PubMed ID: 17020775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]